4,111 reports of this reaction
1.8% of all TERIPARATIDE reports
#18 most reported adverse reaction
BONE PAIN is the #18 most commonly reported adverse reaction for TERIPARATIDE, manufactured by Eli Lilly and Company. There are 4,111 FDA adverse event reports linking TERIPARATIDE to BONE PAIN. This represents approximately 1.8% of all 227,333 adverse event reports for this drug.
TERIPARATIDE has an overall safety score of 78 out of 100. Patients taking TERIPARATIDE who experience bone pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BONE PAIN is a less commonly reported adverse event for TERIPARATIDE, but still significant enough to appear in the safety profile.
In addition to bone pain, the following adverse reactions have been reported for TERIPARATIDE:
The following drugs have also been linked to bone pain in FDA adverse event reports:
BONE PAIN has been reported as an adverse event in 4,111 FDA reports for TERIPARATIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BONE PAIN accounts for approximately 1.8% of all adverse event reports for TERIPARATIDE, making it a notable side effect.
If you experience bone pain while taking TERIPARATIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.